Conduit Pharmaceuticals Announces Reverse Stock Split
I'm PortAI, I can summarize articles.
Conduit Pharmaceuticals (CDT) announced a 1-for-8 reverse stock split, approved by stockholders on May 5, 2025. The split will take effect on October 10, 2025, with trading on a split-adjusted basis starting October 13, 2025, on Nasdaq under the ticker 'CDT'. This move aims to enhance funds for the company's strategic initiatives. Conduit Pharmaceuticals focuses on biopharmaceutical development, leveraging AI and strategic partnerships to advance therapeutic assets and create shareholder value.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments